Table of Content

Global Dengue Market

Chapter 1 Preface
1.1 Report Description

1.1.1 Report Introduction

1.1.2 Target Audience

1.1.3 USP and Key Offerings

1.2 Research Scope

1.3 Market Segmentation

1.4 Research Methodology

1.4.1 Phase I – Secondary Research

1.4.2 Phase II – Primary Research

1.4.3 Phase III – Expert Panel Review

1.4.4 Assumptions

1.4.5 Approach Adopted

1.4.5.1 Bottom-Up Approach
1.4.5.2 Top down Approach
1.4.6 Data Triangulation

1.5 Research Assumptions

1.6 Data Sources

Chapter 2 Executive Summary

Chapter 3 Pipeline Analysis Of Dengue Vaccines

Chapter 4 Epidemiology Outlook Of Dengue Vaccines
4.1 Overview


Chapter 5 Market Dynamics
5.1 Market Drivers

5.1.1 Rising Cases of Dengue

5.1.2 Affordability of Vaccine

5.2 Market Restraints

5.2.1 Lack of awareness

5.3 Opportunity

5.3.1 Clinical Development of Vaccines

Chapter 6 Global Dengue Vaccine Market Analysis, by Demography
6.1 Overview

6.2 Below 5 years

6.3 5-10 years

6.4 Above 10 years

Chapter 7 Global Dengue Vaccine Market Analysis, By End- User
7.1 Overview

7.2 Clinics

7.3 Hospital

7.4 Ambulatory Surgical Centers

7.5 Government/Private Institutes

7.6 Others

Chapter 8 Global Dengue Vaccine Market Analysis
8.1 Introduction


Chapter 9 North America Dengue Vaccine Market Analysis
9.1 Overview

Chapter 10 Europe Dengue Vaccine Market Analysis
10.1 Overview

Chapter 11 Asia Pacific Dengue Vaccine Market Analysis
11.1 Overview

Chapter 12 Latin America Dengue Vaccine Market Analysis
12.1 Overview

12.1.1 Latin America

Chapter 13 Middle East & Africa Dengue Vaccine Market Analysis
13.1 Overview

Chapter 14 Company Profiles
14.1 Sanofi

14.2 Merck & Co., Inc.

14.3 Institut Pasteur

14.4 Takeda Pharmaceutical Company Limited

14.5 GlaxoSmithKline Plc

Chapter 15 Global Strategy of The Companies
15.1 Overview

15.2 Dengue vaccine candidates currently in clinical trials